Homologous DNA recombination levels were measured in normal and spontaneously immortalized murine and human fibroblasts, and in a number of primate and murine established fibroblast cell lines. Immortal cell lines and tumor-derived clones homologously recombined extrachromosomal plasmid substrates at frequencies approximately 100-fold higher than did normal cells. To further explore the mechanism responsible for this phenotype, homologous recombination frequency was measured using nuclear extracts derived from normal and immortalized murine and human fibroblasts. Extracts prepared from immortal cells catalyzed high levels of homologous recombination, whereas very little recombination activity was detected in extracts prepared from normal fibroblasts. Similarly, only extracts derived from immortal cells contained strand-transferase activity as measured by the recently described pairing-onmembrane assay. Mixing experiments indicated that a recombination enhancing factor or factors present in immortal cells, rather than a recombination inhibitor in normal cells, was responsible for the enhanced homologous recombination activity observed using extracts derived from the former.
INTRODUCTION
Genomic instability is a hallmark of oncogenically transformed cells (1, 2) . Deletions, duplications, translocations and loss of ploidy, including hyperdiploidy, are common cytogenetic anomalies seen in tumor cells. It has long been suspected that these, and other genetic alterations are likely to play a fundamental role in the oncogenic process. For the most part, however, it has been difficult to rigorously differentiate amongst those genome rearrangements that play a causative role in cancer, and those events that are an unrelated consequence of it. (Exceptions include the specific translocations associated with certain lymphoid cancers; 2.) It therefore remains uncertain to what extent enhanced genetic instability may predispose a cell to cancer.
Recently, a direct connection between genetic instability and cancer has been detected. Mutations in a number of genes that are homologous to yeast and bacterial DNA mismatch repair genes have been associated with hereditary nonpolyposis colorectal cancer in humans (3) (4) (5) (6) (7) . Individuals heterozygous for such mutations are also more susceptible to cancers of the ovary, endometrium and stomach (8) . Molecular analysis using PCR has determined that tumor cells from these patients contain thousands of mutations, in the form of microsatellite instabilities (9) (10) (11) (12) . Kolodner and Alani (13) provided evidence that these mutations are also seen in sporadic tumors, suggesting that deficiencies in DNA mismatch repair may be a common aspect of human carcinogenesis. It has also been shown that cells with mutations in these genes display a mutator phenotype in vitro (14) , and are profoundly incapable of repairing mismatched DNA (15, 16) .
It therefore seems likely that, as a result of deficient DNA mismatch repair, misincorporation of nucleotides during DNA replication results in the creation of a host of mutations that eventually leads to cellular transformation. However, it is conceivable that a deficient mismatch repair mechanism could also predispose cells to cancer through an entirely distinct mechanism. Experiments conducted in bacteria (17, 18) and yeast (19, 20) indicate that inactivation of cellular mismatch repair mechanisms results in greatly enhanced levels of recombination between partially identical DNA sequences (homeologous recombination). A similar observation has very recently been made in mammalian cells. While a lack of complete sequence identity between recombination substrates greatly reduces the frequency of gene targeting in wild-type mouse ES cells, gene targeting frequency is not similarly reduced in ES cells that lack a functional Msh2 mismatch repair gene (21) . These observations raise the possibility that some of the chromosomal rearrangements seen in cancer cells may result from aberrant homologous recombination.
Consistent with this idea, it has previously been shown that homologous intra-plasmid recombination occurs at higher levels in human tumor-derived cells and virally transformed clones, than in normal diploid fibroblasts (22) . However, it remains unclear whether this elevated homologous recombination activity contributes to the oncogenic process, or is instead a nonspecific consequence of it. In order to provide such information, it will be necessary to gain greater insight into molecular mechanisms responsible for the observed differences in homologous recombination activity seen in normal and immortal cells.
Toward this goal, biochemical and genetic homologous recombination assays were used to characterize homologous recombination activity in normal and immortalized mammalian somatic cells. We have determined that immortal cells possess homologous recombination levels that are nearly 100-fold higher than those observed in normal cells. We present evidence suggesting that it is the presence of a positively acting, homologous recombination enhancing activity within immortal cells that is responsible for this distinction. Consistent with this interpretation, we used a recently described strand-transferase assay (23, 24) to identify putative strand-transferase proteins that are present in protein extracts derived from immortalized cells but that appear to be either absent or inactive in similar extracts made from normal cells.
MATERIALS AND METHODS

Cells
HT1080 (human spontaneous fibrosarcoma; 25) and CV-1 (immortal African green monkey kidney; 26) cells were obtained from the ATCC. Murine 3T3 and 3T6 cells (immortal cells derived from murine embryo fibroblasts; 12) were the kind gift of Dr Li-Na Wei, University of Minnesota. COS-1 (SV40 transformed CV-1 derived; 28) cells were provided by Dr Ping Law, University of Minnesota. Normal human fibroblasts were the kind gift of Dr Robert O'Dea, University of Minnesota. Murine embryo fibroblasts were derived from a FVB-N strain mouse (Jackson Labs) as described by Green and Todaro (27) . Murine embryo fibroblast (MEF) cells were used between passage numbers 1 and 8. Within this range of passage number, we detected no discernible difference in their growth rate, morphology, or homologous recombination activity. Spontaneously immortalized MEF cells (referred to as MEF-Im) were obtained by serially passaging the MEF cells until senescence, and subsequently isolating and expanding foci. In our hands this process required at least 12 serial passages of 1 in 3.
Homologous recombination assays
To measure extrachromosomal inter-plasmid HR in primate cells, the plasmids pSV2neoDL and pSV2neoDR (a kind gift of Dr Raju Kucherlapati, Albert Einstein College of Medicine, see Fig. 1 ) were co-transfected into recipient cells along with pRSVedl884, a plasmid encoding the SV40-derived large T antigen (28) , using the calcium phosphate co-precipitation protocol (29) . Ten micrograms of each plasmid was used per 10 cm dish, and in all cases, the plasmids were supercoiled. Construction of plasmids pSV2neoDL [248 base pair deletion within the 5′ portion of the neomycin phosphotransferase (neo) gene] and pSV2neoDR (283 base pair deletion within the 3′ portion of the neo gene), each of which harbors a non-reverting, inactivating deletion mutation within the coding region of the neomycin phosphotranferase gene from Tn5, has been described (30) .
Following transfection, cells were incubated in growth media for 48 h prior to the recovery of plasmid DNA (31) . This low molecular weight DNA was restriction digested with an excess of DpnI. This material was then used to transform electro-competent Escherichia coli (strain DH10B, recA deficient). A portion of the transformation mix was plated on ampicillin-containing plates, while the remainder was plated on kanamycin-containing plates. The HR frequency was determined by the ratio of double resistant (ampicillin and kanamycin) colonies to ampicillin resistant colonies. [The plasmid pRSVedl884 (32) lacks an SV40 origin of replication, and will not replicate under the conditions used in our assay, while both the recombination substrate plasmids contain an SV40 origin of replication, and will replicate. As a consequence of this, only pSV2neo-derived plasmids will survive DpnI digestion and be measured in the bacterial transformation assay.]
To measure HR in murine cells, the plasmids pSV2neoDLPy and pSV2neoDRPy were co-transfected into recipient murine cells, and further processed as described above. Both of these plasmids, which replicate autonomously in murine cells were created by introducing the early region of polyoma virus into the BamHI sites of pSV2neoDL and pSV2neoDR. Control experiments indicate that wild-type and deletion-bearing plasmids replicate at essentially identical rates in both normal and immortal cells.
For transfection-based assays involving both murine and human cells, an important control involved directly co-transforming recombination deficient E.coli with 0.5 µg of each of the recombination substrates (either pSV2neoDR and pSV2neoDL, or pSV2neoDLPy and pSV2neoDRPy). A portion of these bacteria were then plated on ampicillin-containing agar plates, and the majority plated on plates containing ampicillin and kanamycin. Under these conditions, we observed a very low level of HR activity, carried out by the E.coli. As shown in Table 1 , the level of this activity is significantly lower than that seen in any of the transfection-based experiments. a HR frequency is expressed as the number of kanamycin-resistant colonies per 100 000 ampicillin-resistant colonies. b An experiment refers to an independent transfection. The total number of kanamycin-and ampicillin-resistant colonies from each set of these transfections was summed and used to calculate the average HR frequency. c 0.5 µg of the recombination substrate plasmids were co-transformed into E.coli and the number of ampicillin-and kanamycin-resistant colonies determined. Both substrate plasmids contain an ampicillin resistance gene, depicted by the shaded box. In addition, the presence of PstI sites on both are depicted by asterisks. In this illustration, a single reciprocal recombination event generates a dimeric plasmid (C) harboring one intact, functional neo gene (indicated by the white box) and one neo gene harboring both the deletions (indicated by the black triangles). Note that dimeric plasmids may subsequently undergo intra-molecular recombination to generate monomers (see text). In addition, wild-type neomycin phosphotransferase genes may also be generated via gene conversion or double-reciprocal recombination events.
Cell-free HR was determined by incubating plasmids that harbored non-overlapping deletions within the neo gene separately or together with nuclear protein extracts prepared from the respective cell types (33) . In some experiments double-stranded plasmids pSV2neoDL and pSV2neoDR were utilized, while in the others, a single-stranded M13mp18 derivative containing the neoDR allele (ssneoDR) was used in conjunction with pSV2neoDL linearized with the restriction endonuclease SalI (see Fig. 1 , and text). Following a 30 min incubation at 37_C as described (33) , the plasmid DNA (500 ng of each substrate) was extracted with phenol: chloroform (1:1), ethanol precipitated, and used to transform recA deficient E.coli (strain DH10B). DNA from the separate plasmid incubations was pooled prior to transformation. The number of kanamycin (recombinant) and ampicillin (non-recombinant) resistant colonies were counted. The homologous recombination frequency obtained from separate plasmid incubations was calculated, and subtracted from that obtained from co-incubation experiments. We directly co-transformed un-treated DNA recombination substrates into E.coli, and measured the HR frequency. As indicated in Table 2 , we did not obtain any kanamycin-resistant colonies under these conditions. We also performed an additional control in which the plasmid pSV2neo (which harbors intact neomycin-and ampicillin-resistance markers) was incubated with a nuclear protein extract, and subsequently transformed into recombination-deficient E.coli. In these experiments, the ratio of kanamycin-resistance to ampicillinresistance was 1.04 ± 0.16. This result indicates that there is no inherent difficulty in recovering kanamycin-resistant bacteria following incubation of plasmid DNA with a nuclear protein extract.
Nuclear extracts
Extracts were prepared as previously described (33) . Protein concentration was determined using the Bradford assay (34). We empirically determined the amount of protein necessary to obtain maximal activity. In all cases tested this corresponded to 5 µg protein in a reaction volume of 50 µl (see Table 3 ).
Pairing on membrane (POM) assay
Nuclear extracts prepared as described above were separated using polyacrylamide gel electrophoresis in the presence of SDS (35) , and electrophoretically transferred to a nitrocellulose membrane (Bio-Rad). Putative strand-transferase proteins were identified using the POM assay described by Akhmedov et al. (23) . 
RESULTS
Homologous DNA recombination (HR) activity is elevated in immortal mammalian somatic cells
It has been previously shown that homologous intra-plasmid recombination levels in immortalized human cells are significantly greater than those seen in diploid fibroblasts (22) . To confirm and extend this observation, and gain additional insight into the mechanism through which this process occurs, we measured HR levels in immortal and normal cells derived from human, non-human primate and murine sources. A co-transfection assay Nucleic Acids Research, 1996, Vol. 24, No. 20 4087 was used to measure the frequency with which two plasmid molecules, transiently present within the nuclei of cultured cells, homologously recombine. This assay is depicted schematically in Figure 1 , and is described in detail in the Materials and Methods. Due to the limited replicative life-span of normal fibroblasts in culture, it is not feasible to use other, more traditional methods to measure HR frequency that involve selection for stably transfected drug-resistant clones. Transfected plasmid molecules are capable of replication within mammalian cells in the presence of the SV40 large T antigen. Plasmid DNA recovered from transfected cells is subsequently treated with the restriction endonuclease DpnI, which will digest only the parental, unreplicated plasmid DNA (originally isolated from an E.coli host that methylates adenine residues located within the sequence GATC). This treatment was done to ensure that all plasmid DNA analyzed further has replicated within the transfected cells. We performed a number of control experiments (not shown) in which the SV40 large T antigen-encoding plasmid pRSVedl884 was omitted from the transfection mixture. When low-molecular weight DNA was recovered from these cells, treated with DpnI, and used to transform E.coli, no ampicillin-or kanamycin-resistant colonies were observed. This result proves that DpnI digestion eliminates plasmids that have not replicated.
We have incorporated plasmid replication into our transfection protocol for two reasons. First, this intracellular amplification enhances the yield of plasmids, providing greater numbers of both recombinant, and non-recombinant molecules for subsequent analysis. In light of previous results indicating that HR levels in normal cells are quite low (22) , obtaining greater numbers of plasmids to analyze would provide HR frequency values of greater accuracy. Second, we were concerned that, if a substantial proportion of the DNA used to transfect the mammalian cell lines never entered the nucleus of the recipient cell line, it would be difficult to accurately compare HR frequencies amongst the various cell lines tested. By digesting with DpnI, we have been able to ensure that all of the molecules used to generate bacterial colonies, in the final step of the assay, were originally within the recipient mammalian cell line.
Since we have used a large amount of the SV40 large T antigen encoding plasmid (pRSVedl884), it is likely that the majority of plasmid DNA within these transfected cells will have undergone at least one round of replication. While we are not controlling for transfection efficiency, per se, by digesting the low molecular weight DNA with DpnI we are providing reasonable assurance that the HR frequencies from different cell lines can be accurately compared. Previous investigations have determined that plasmid replication does not influence the frequency of extra-chromosomal HR in mammalian somatic cells (22) .
The results from a number of transfection experiments ( Table 1 ), show that all of the immortalized cells possess robust recombination activity, while the normal fibroblasts are significantly less recombinogenic. We observed that non-immortalized human dermal fibroblasts were about 70-fold less recombinogenic than the human fibrosarcoma line HT1080. Levels of HR in the spontaneously immortalized MEF cells were elevated over those seen in normal MEFs to a similar extent (∼85-fold). These observations are similar to those previously reported by Finn et al. (22) , in which HR levels were elevated approximately 10-fold following viral transformation (see Discussion). The HR activity described by Finn et al. (22) involved an intra-plasmid event, while the recombination events we are describing in this report involve two distinct plasmid molecules. We therefore constructed a plasmid molecule that harbored both the neoDL and neoDR alleles in a direct-repeat orientation. This molecule (pSV2neoDL: DR[D]) was used to transfect HT1080 and HDF cells, and the frequency of HR measured as described above. We determined that intra-plasmid HR frequency for HDF cells was 10 kanamycin-resistant colonies per 10 5 ampicillin-resistant colonies (168 kanamycin-resistant colonies/ 1 688 730 ampicillin-resistant colonies), while that for HT1080 cells was 630 kanamycin-resistant colonies per 10 5 ampicillin-resistant colonies (179 kanamycin-resistant colonies/ 28 485 ampicillinresistant colonies). Careful comparison of both the intra-plasmid and inter-plasmid HR frequencies reveals that the HT1080 cells are 62-fold more active in inter-plasmid HR, and 63-fold more active in intra-plasmid HR, relative to the HDF cells.
Molecular characterization of HR products
To confirm that homologous recombination had occurred following transfection, plasmid DNA prepared from kanamycin-resistant bacterial colonies was subjected to restriction digestion analysis using the endonuclease PstI. The plasmids pSV2neoDR and pSV2neoDL can be easily distinguished from full-length pSV2neo, following digestion with this restriction endonuclease (see Fig. 2, lanes 1-3) . When a number of kanamycin resistant colonies were analyzed in this way, they all contained an intact neomycin phosphotransferase gene (representative examples are shown in Fig. 2, lanes 4 and 5) . In contrast to the recombinant products observed following cell-free HR reactions (see below) all of the plasmids analyzed in this fashion were monomeric.
It is important to note that while the levels of HR seen in the normal cells (MEF and human diploid fibroblasts) are very low, they are at least 10-fold higher than levels that are observed when pSV2neoDR and pSV2neoDL are co-transformed directly into DH10B bacteria (Table 1) . It is also noteworthy that the levels of HR activity in different immortalized cell lines vary considerably, in agreement with previous reports (22, 36) .
HR levels are elevated in protein extracts prepared from immortal cells
The previous results provided evidence that both murine and human normal cells are significantly less capable of catalyzing HR between plasmids than their immortalized counterparts. However, these transfection-based results must be interpreted cautiously, since it is possible that other factors such as differential plasmid transfection or replication within the various cells tested could influence the results in an unpredictable fashion. With these concerns in mind, we pursued a biochemical approach to confirm this observation. Nuclear protein extracts were prepared from a number of normal and immortalized cell lines, to determine whether the same pattern of recombination activity would be observed. The use of this approach would overcome a number of theoretical objections based upon the transfection-based assay (see Discussion), and provide more direct confirmation that immortalized cells possess more HR activity than normal cells.
In the cell-free HR assay (37), two different kinds of DNA substrates were used. Experiments were conducted using: (i) a single-stranded derivative of pSV2neoDR along with linearized, double-stranded pSV2neoDL; and (ii) circular, double-stranded pSV2neoDR and pSV2neoDL. Using the cell-free HR assay described in the Materials and Methods, we determined that all of the immortalized cell lines efficiently catalyze HR ( Table 2 ). This was true irrespective of which DNA substrates were used. As indicated in Table 2 , the absolute value of the HR frequency measured using these two double-stranded circular plasmids was about 100-fold lower than the corresponding value obtained from the single-strand circular, double-strand linear substrate combination. (This observation, which has been made previously, see reference 37, is probably due to the relative inefficiency with which the linearized plasmid pSV2neoDL transforms bacteria, thereby dramatically reducing the number of ampicillin-resistant colonies recovered.) In contrast, inspection of the data in Table 2 indicates that the levels of HR activity in normal cells was negligible when compared with that seen in immortal cells. We tested both of the human dermal fibroblasts strains identified above, and found that neither possessed detectable HR activity. Although the parental murine embryo fibroblasts possessed a low level of HR activity when assayed with the single-strand and linearized double-strand DNA substrates, this was not statistically greater than the background levels of HR seen in control experiments in which the two recombination substrates were separately incubated with extract, and then subsequently combined and introduced into the recA E.coli strain used in these experiments.
To gain insight into the nature of the cell-free recombination reaction we performed restriction analysis of plasmid DNA obtained from kanamycin-resistant colonies resulting from co-incubation of pSV2neoDL and pSV2neoDR with nuclear protein extracts. In a majority of cases, the bacteria harbored two plasmids. One plasmid invariably harbored a full-length neomycin phosphotransferase gene conferring kanamycin resistance. The second plasmid generally corresponded to one of the two non-recombinant (i.e. DL or DR) plasmids, although occasionally a plasmid contained a double deletion-bearing neomycin phosphotransferase gene was recovered. The two plasmids found in these bacteria were present as either monomers, or occasionally, as dimers. It is unknown to what extent interconversion of these two forms can occur within the recombination-deficient E.coli host. In any event, it is clear that the products recovered are those expected from conservative recombination reactions (as opposed to what would result from a nuclease-mediated annealing reaction), and strongly argue that the kanamycin-resistant bacterial colonies arise as a consequence of legitimate HR events catalyzed by the nuclear protein extracts. These experiments indicate that nuclear extracts from immortalized and transformed cells possess much higher levels of HR activity when compared with extracts from normal cells. Normal cell extracts do not inhibit HR activity in immortalized cell extracts. Cell-free HR assays were performed as described in the Materials and Methods, using extracts derived from HT1080 cells and human diploid fibroblasts. One or 3 µg of HT1080 nuclear extracts were assayed in the absence, blank columns, or presence, filled columns, of 5 µg of nuclear extract prepared from normal human diploid fibroblasts. Each experiment was performed at least three times, and the frequency values averaged. The standard error of the mean is indicated by error bars.
Biochemical characterization of cell-free HR activity
As outlined in Table 3 , we observed that heat treatment of the protein extract destroyed the recombination activity, and that the activity was almost entirely dependent upon added ATP. We also observed that the nuclear HR activity was barely detected when the ATP analog ATP[γ]S was present. In addition, the HR activity occurred in the apparent absence of DNA synthesis, since there was no requirement for exogenous deoxynucleoside triphosphates (data not shown) and the DNA polymerase inhibitors aphidicolin and dideoxy adenosine triphosphate did not diminish HR activity (Table 3) .
Nuclear extracts from normal cells do not inhibit HR activity in immortal cell extracts
The presence of enhanced HR activities in immortalized cells may reflect the acquisition of new enzymatic activity, implying the activation of normally quiescent genes, or alternatively, the loss of recombination inhibitors that are normally present. We reasoned that if an inhibitor of HR were present in normal cells, mixed extracts from the two cells would show diminished levels of HR, while if an enhancer of recombination were present in immortalized cells, the mixed extract would have levels of HR activity nearly the same as the immortalized cells. To distinguish between these two hypotheses, we conducted the experiments outlined in Figure 3 . As Figure 3 indicates, addition of 5 µg of protein derived from normal fibroblast nuclei did not decrease the activity present in either 1 µg or 3 µg of nuclear protein derived from immortal cells (there is no inherent activity seen with 5 µg of nuclear protein from normal cells). Due to the relatively large standard errors, it was not possible to determine whether there was in fact some synergistic activation of the protein from the normal cells. It is possible that an abundance of some activity present in the immortalized cells can act in concert with other proteins constitutively present in the normal cells, and thus explain the very modest increase seen in the assays in which extracts from the two cells were mixed.
Identification of strand-exchange proteins present in immortal but not normal cell extracts
To further confirm that increased levels of HR proteins are present within the nuclei of immortal cells, we utilized the newly described pairing on membrane (POM) assay (23, 24) . This assay measures the ability of proteins that have been electrophoretically separated and transferred to nitrocellulose to catalyze DNA strand-transfer between single-stranded circular DNA that has been previously immobilized upon the membrane, and radiolabelled homologous double-stranded linear molecules that are present in solution. Nuclear protein extracts from normal and immortal cells were separated by SDS-polyacrylamide gel electrophoresis (35) , and transferred to a membrane that had been coated with single-stranded circular φX174 DNA. This membrane was incubated with linearized, double-stranded φX174 DNA that had been radiolabelled at its 3′ ends, as described by Akhmedov et al. (23) . A number of hybridization signals, indicating the presence of apparent strand-transferase proteins, were observed in extracts from immortal cells ( Figure 4A, lanes 2, 4, 5, and 6 ), while essentially no radioactive products were seen in extracts made from normal human and murine cells (lanes 1 and3, respectively ). An identical SDS-polyacrylamide gel, stained with Coomassie blue is shown in Figure 4B . Parallel experiments in which double stranded, radiolabelled M13 DNA was used in place of φX174 (the two phage genomes share no significant sequence similarity) did not produce radioactive signals in any of the protein samples tested (data not shown). This latter observation, which was repeated three times, indicates that the hybridization signals seen in Figure 4 require homology between the single-and doublestranded DNA molecules.
DISCUSSION
We have utilized three different recombination assays to show immortalized cells are significantly more capable of catalyzing HR than are normal cells. These observations were made in both mouse and human cells, and in spontaneously immortalized and established cell lines. First, we used co-transfection of two plasmids to measure inter-plasmid extrachromosomal HR (Table 1) . Our data are in agreement with a previous report in which extrachromosomal intra-plasmid recombination was shown to be elevated in virally transformed human fibroblasts and a number of established cell lines (22) . We have extended this observation to include spontaneously immortalized murine and non-human primate cells. The extent to which immortalization enhances HR is somewhat difficult to determine, since different immortalized cell lines differ in their HR frequency ( Table 1; 22 and 36) . Nevertheless, our data indicate that the level of enhancement can be quite significant, since immortalized MEF cells are 85-fold more recombinogenic than the cells from which they are derived. Similarly, the fibrosarcoma-derived cell line HT1080 is 62-fold more recombinogenic than either of the normal human dermal fibroblast strains tested. Experiments performed on HT1080 and normal human diploid fibroblast cells indicated that intra-molecular HR was also ∼60-fold more frequent in the former, compared with the latter. We also noted that the absolute levels of intra-molecular HR were approximately 10-fold higher than the levels of inter-molecular HR. These results are in qualitative agreement with a previous observation (22) that indicated immortalization resulted in an increase in intra-molecular plasmid HR frequency. (This observation also suggests a likely explanation for the absence of dimeric recombinant plasmids following co-transfection of pSV2neoDL and pSV2neoDR into mammalian somatic cells; these dimers share extensive homology which probably leads to intra-molecular recombination, generating monomer plasmids.)
The results presented in Table 1 were obtained by summing all of the kanamycin-resistant and ampicillin-resistant colonies obtained from a number of separate transfections. We used this approach, rather than presenting the data as the mean value obtained from each separate transfection because, in the case of the normal mammalian somatic cells, we frequently did not obtain any kanamycin-resistant colonies from a particular transfection. In the case of the human HT1080 cell line, it is possible to calculate mean and standard error values by analyzing the results of a number of separate experiments, since each transfection yielded kanamycin-resistant colonies. We have performed this analysis on two sub-clones of the HT1080 cell line, and determined that the HR frequency is 81 ± 7, and 60 ± 13 kanamycin-resistant colonies per 10 5 ampicillin-resistant colonies, respectively. The former subclone of HT1080 was the one used in the experiments shown in Table 1 -3. These results demonstrate that the HR frequency values we have measured are highly reproducible. We have also performed this type analysis on the intra-plasmid HR experiments conducted with HDF and HT1080 cells. Here we have determined that the intra-plasmid HR frequency of the former is 10 ± 1.6, while that of the latter is 628 ± 55 (in both cases, this value refers to the number of kanamycin-resistant colonies per 10 5 ampicillin-resistant colonies, plus or minus the standard error of the mean.)
While all of the immortal cells possess HR levels significantly greater than those seen in the normal human or mouse fibroblasts, we see no obvious relationship between HR activity and species of origin. In addition, there does not appear to be a correlation between the amount of plasmid DNA that has replicated within a cell line (and is resistant to DpnI digestion) and HR activity. Murine 3T3 cells yielded relatively few ampicillin-resistant colonies (Table  1) , and had one of the higher HR activities, whereas MEF cells yielded many-fold more ampicillin-resistant colonies, and gave the lowest HR frequency (Table 1) . It is therefore unlikely that enhanced HR is the result of increased concentrations of plasmid molecules within the cells. A recent paper has shown that the search for homology does not represent a rate-limiting step in mammalian somatic cell HR (38) . It is therefore not likely that the HR frequency data presented in Table 1 reflects differences in transfection efficiency amongst the various cell lines tested.
There also does not appear to be a correlation between the frequency of cellular HR and the cell cycle. For example, we measured the growth rate of both normal and immortalized MEF cells. While the latter does grow slightly faster than the former (less than two-fold difference in the double time, not shown), its HR frequency is about 85-fold greater than normal MEF cells. In contrast, the growth rate of CV-1 cells is intermediate between that of the normal and immortalized MEF cells, yet, as Table 1 indicates, its HR frequency is even greater than that of the immortalized MEF cells. It is therefore unlikely that the very great disparity between HR frequency seen in normal and immortal clones may be explained on the basis of differences in the cell division cycle of these respective cells.
A number of theoretical objections to the use of a transfectionbased assay to compare HR frequencies amongst different cell lines can be raised. Using this assay, it is not possible to ensure that additional factors, such as the extent to which plasmid transfection efficiency, or replication are not responsible for the different HR frequencies observed. For this reason, we utilized two additional HR assays, in which any of the objections raised to the transfection assay will not apply.
First a cell-free homologous recombination assay allowed us to independently confirm that immortalized cells contain significantly more HR activity than do normal cells (Table 2 ). Since the levels of HR activity of both of the normal human cell strains used in this assay were undetectable, it was not possible to measure the extent to which immortalization enhanced HR levels. However, the HR frequency observed in murine embryo fibroblasts (MEFs) that had spontaneously immortalized was approximately 60-fold higher than that seen in the parental MEF cells. It is remarkable that both the transfection-based assay and the nuclear extractbased assay indicate that immortalization stimulates HR levels to a similar extent (62 to 85-fold, versus 60-fold, respectively). We performed a Spearman-rank correlation test, in which the HR data [cell lines COS-1, 3T3, MEF (immortalized), HT1080, MEF (normal) and HDF] from these two different assays were compared. This analysis reveals a correlation coefficient of 0.9, (P = 0.019), strongly suggesting that HR levels measured using the transfection-based assay are not biased by features such as differential transfection efficiency, plasmid replication, which are not relevant to the cell-free HR assay.
The ability to measure HR using cell-free extracts allowed us to address a number of questions. The first is whether the ability of immortalized cells to catalyze HR represents the acquisition of a novel activity or, conversely, the loss of normal inhibitory proteins. As presented in Figure 3 , our data suggest the former, since the addition of normal cell extract to immortalized cell extract did not have a detectable inhibitory effect on the level of activity observed when the immortal cell extract was tested alone.
This observation was made with two different concentrations of immortal cell extract, well within the region where increasing protein yielded increasing amounts of homologous recombinants (Table 2 ). These data are therefore consistent with the interpretation that normal cells lack a factor or factors that, when present, greatly stimulate HR. We acknowledge, however, that there may be other interpretations of these data (see below).
Experiments using the pairing-on-membrane (POM; 23,24) assay support the conclusion that immortal cells possess higher levels of HR than their normal counterparts. As shown in Figure 4 , high levels of active strand-transferase proteins are present in nuclear extracts of immortal, but not normal, cells. Upon close inspection there is a small amount of strand-transferase activity in lane 3 of Figure 4A , corresponding to the nuclear extract prepared from MEF cells. This observation may reflect a low constitutive level of strand-transferase activity present in all the cells of the population, or it may be the result of small numbers of immortalized MEF cells present within the normal cell population. Since MEF cells are known to undergo frequent spontaneous immortalization, we favor the latter hypothesis, particularly since no such strand-transferase activity is detectable in the normal human cells (Fig. 4A, lane 1) , which are not susceptible to spontaneous immortalization.
We detect the presence of three to four strand-transferase proteins in extracts from immortal cells. It remains to be determined whether these results indicate the coordinate expression of a number of distinct proteins. Alternately, it is possible that these multiple signals represent post-translational modifications, or the proteolytic breakdown products of a smaller number of precursor proteins.
The POM assay results provide additional support for the conclusion that the enhanced level of HR in immortal cells is the result of the synthesis of novel enzymes that are not expressed in normal cells. Since the presence of DTT and SDS within the electrophoresis buffer disrupts protein-protein interactions, a protein could inhibit strand-transferase activity only if it were of the same molecular weight as the strand-transferase itself. Therefore, if one assumes that the strand-transferases observed in Figure 4A are responsible for the HR activity measured by the experiments shown in Table 1 and 2, two interpretations are possible. The first is that the strand-transferase (HR) protein is absent from normal cells, but present in immortal cells. Alternatively, constitutively expressed HR proteins may be post-translationally modified in immortal cells through a process that does not occur in normal cells. For example, it is possible that a protein kinase required to activate strand-transferases is present within immortalized cells, but absent in normal cells. For this model to be true, it must be assumed that this kinase is either absent or incapable of functioning when the immortal and normal cell extracts are mixed.
We cannot differentiate between these two hypotheses at this time. Having identified a number of strand-transferase proteins (Fig. 4A) , it may be possible to determine whether proteins of similar molecular weight are differentially phosphorylated, or otherwise modified in normal versus immortal cells. In addition, it may now be possible to purify these proteins and clone the genes that encode them. We believe that this approach may ultimately lead to the identification of novel genes that play an important role in oncogenic transformation.
The major issue raised by this work concerns the role that HR plays in the oncogenic process. As was outlined in the introduction, a plausible, if speculative, argument can be made that HR plays a role in the genomic rearrangements that appear to play a role in oncogenesis. Although additional work will be required to establish a clear correlation between genomic instability and elevated HR activity, our results do indicate that elevated levels of HR are seen at early stages in the transformation process. The MEFs used in this study were between passage numbers 1 and 8. There is no relationship between passage number and HR frequency within this range of passage number, however, as soon as we can identify and isolate spontaneously immortalized murine embryo fibroblasts, they show elevated levels of HR activity, as well as numerous strand-transferase proteins. (In addition, our results indicate that elevated HR activity is a common, if not ubiquitous feature of immortalized cells.) Results from mixing experiments, and from the POM assay both suggest that the enhanced levels of HR seen in immortal cells are likely to result from the induction of recombination activity, rather than the loss of recombination inhibitors. To conclusively rule out other interpretations, however, will require more detailed studies.
Based on the data presented here, it would be premature to conclude that altered HR levels play a direct causative role in oncogenesis. However, it seems reasonable to propose that elevated HR levels may help to confer a growth advantage on mammalian somatic cells. As was outlined in the introduction, mutations that confer a mutator phenotype on human cells are clearly cancer pre-disposing. Enhanced cellular HR may contribute to increased genomic instability, and thereby facilitate the genetic events that lead to transformation. It is therefore likely that a greater understanding of the molecular genetics of HR in mammalian somatic cells will provide additional insight into the process of oncogenesis.
